Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.

Breast Cancer Res · 2010 · PMC3046450 · PMID 21122106

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In this cohort, patients with ER receptor-negative tumors additionally demonstrated a clear trend, although not statistically significant ( P = 0.111, data not shown), for improved survival in methylated tumors.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.